The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

A decision is expected in the fourth quarter of 2025.

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...